Catalyst Wire Dossier Catalyst Wire Dossier

Anti-HER-2 cell therapy

· National Cancer Institute (NCI)
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Anti-HER-2 cell therapy, covering 2012-02-14 to 2012-02-14. Get the full timeline:

Most recent: Clinical Trial Update: Gene Therapy Using Anti-Her-2 Cells to Treat Metastatic Cancer [Phase 1, Phase 2]

See pricing